New Tools Enable Gene Delivery

Electroporator Suppliers Lipid Transfection Reagents - Supplemental Table not in Print Edition Virus Transduction Reagents - Supplemental Table not in Print Edition Equibio Ltd.'s CelljecT Pro system Technologies that introduce DNA and RNA into eukaryotic cells, tissues, or organisms provide opportunities to study the regulation and function of genes and proteins. The biggest barrier that these technologies must overcome is the cell membrane, which is not permeable to highly charged macromol

Written byDeborah Stull
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Electroporator Suppliers

Lipid Transfection Reagents - Supplemental Table not in Print Edition

Virus Transduction Reagents - Supplemental Table not in Print Edition


Equibio Ltd.'s CelljecT Pro system
Technologies that introduce DNA and RNA into eukaryotic cells, tissues, or organisms provide opportunities to study the regulation and function of genes and proteins. The biggest barrier that these technologies must overcome is the cell membrane, which is not permeable to highly charged macromolecules such as DNA. Nevertheless, researchers have developed numerous approaches to overcome this challenge, including liposome-mediated and calcium phosphate (CaPO4)-mediated transfection, electroporation, and viral transduction.

Each of these methods has advantages and disadvantages, often requiring researchers to compromise on one aspect of their experiment to maximize another. As a result, companies continue to improve existing technologies and to develop new ones that decrease the expense of transfection experiments, increase their efficiency, and enable transferring from one system or cell type ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies